Innovative Metal-Organic Frameworks for Targeted Oral Cancer Therapy: A Review

Author:

Mousavi Seyyed Mojtaba1,Hashemi Seyyed Alireza2ORCID,Fallahi Nezhad Fatemeh3,Binazadeh Mojtaba4ORCID,Dehdashtijahromi Milad4,Omidifar Navid5,Ghahramani Yasamin6,Lai Chin Wei7ORCID,Chiang Wei-Hung1ORCID,Gholami Ahmad3ORCID

Affiliation:

1. Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei 10607, Taiwan

2. Nanomaterials and Polymer Nanocomposites Laboratory, School of Engineering, University of British Columbia, Kelowna, BC V1V 1V7, Canada

3. Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran

4. Department of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz 71557-13876, Iran

5. Department of Pathology, Shiraz University of Medical Sciences, Shiraz 71439-14693, Iran

6. Associate Professor of Endodontics Department of Endodontics, School of Dentistry Oral and Dental Disease Research Center Shiraz University of Medical Sciences, Shiraz 71956-15787, Iran

7. Nanotechnology & Catalysis Research Centre (NANOCAT), University of Malaya (UM), Kuala Lumpur 50603, Malaysia

Abstract

Metal-organic frameworks (MOFs) have proven to be very effective carriers for drug delivery in various biological applications. In recent years, the development of hybrid nanostructures has made significant progress, including developing an innovative MOF-loaded nanocomposite with a highly porous structure and low toxicity that can be used to fabricate core-shell nanocomposites by combining complementary materials. This review study discusses using MOF materials in cancer treatment, imaging, and antibacterial effects, focusing on oral cancer cells. For patients with oral cancer, we offer a regular program for accurately designing and producing various anticancer and antibacterial agents to achieve maximum effectiveness and the lowest side effects. Also, we want to ensure that the anticancer agent works optimally and has as few side effects as possible before it is tested in vitro and in vivo. It is also essential that new anticancer drugs for cancer treatment are tested for efficacy and safety before they go into further research.

Publisher

MDPI AG

Subject

General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3